These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 16005993)

  • 1. Delayed stenting of a thrombotic saphenous vein graft after intravenous tirofiban pretreatment.
    Niccoli G; De Vita M; Maria Leone A; Biscione C; Mongiardo R; Rebuzzi A; Crea F
    Int J Cardiol; 2006 Jun; 110(1):108-9. PubMed ID: 16005993
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of tirofiban and clopidogrel pretreatment on outcome of old saphenous vein graft stenting in patients with acute coronary syndromes.
    Ozkan M; Sag C; Yokusoglu M; Uzun M; Baysan O; Erinc K; Isik E
    Tohoku J Exp Med; 2005 May; 206(1):7-13. PubMed ID: 15802870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of saphenous venous graft thrombus by tirofiban infusion.
    Sentürk T; Aydin Kaderli A; Aydin O; Yeşilbursa D; Akin Serdar O
    Heart Lung; 2010; 39(3):237-9. PubMed ID: 20457345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban.
    Assali AR; Sdringola S; Ghani M; Westbrook LA; Anderson HV; Schroth G; Fujise K; Smalling RW; Rosales OR
    J Invasive Cardiol; 2000 Sep; 12(9):460-3. PubMed ID: 10973371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute central retinal artery occlusionwith the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban.
    Hölschermann H; Krombach C; Jung A; Jacobi F; Tillmanns H; Weinand F
    Thromb Haemost; 2005 Sep; 94(3):684-6. PubMed ID: 16268493
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment during saphenous vein graft stenting: differential effects after randomization to occlusion or filter-based embolic protection.
    Jonas M; Stone GW; Mehran R; Hermiller J; Feldman R; Herrmann HC; Cox DA; Kuntz RE; Popma JJ; Rogers C;
    Eur Heart J; 2006 Apr; 27(8):920-8. PubMed ID: 16415300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iliac artery thrombosis after aortic balloon counterpulsation: treatment with intraarterial tirofiban, manual thrombectomy and stenting.
    Rigatelli G; Giordan M; Cardaioli P; Maronati L; Magro B; Roncon L; Zonzin P
    Int J Cardiol; 2006 Oct; 112(3):387-8. PubMed ID: 16257068
    [No Abstract]   [Full Text] [Related]  

  • 8. Tirofiban and emergency coronary surgery.
    Shanmugam G
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):546-50. PubMed ID: 16126403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
    Durand M; Lecompte T; Hacquard M; Carteaux JP
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):687-9. PubMed ID: 18579401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early discharge is feasible following primary percutaneous coronary intervention with transradial stent implantation under platelet glycoprotein IIb/IIIa receptor blockade. Results of the AGGRASTENT Trial.
    Dirksen MT; Ronner E; Laarman GJ; van Heerebeek L; Slagboom T; van der Wieken LR; van der Wouw PA; Kiemeneij F
    J Invasive Cardiol; 2005 Oct; 17(10):512-7. PubMed ID: 16204742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.
    Karha J; Gurm HS; Rajagopal V; Fathi R; Bavry AA; Brener SJ; Lincoff AM; Ellis SG; Bhatt DL
    Am J Cardiol; 2006 Oct; 98(7):906-10. PubMed ID: 16996871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.
    Thomas MD; Wood C; Lovett M; Dembo L; O'Driscoll G
    J Heart Lung Transplant; 2008 Aug; 27(8):925-7. PubMed ID: 18656810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts.
    Kurowski V; Toelg R; Jain D; Richter C; Wiegand UK; Richardt G; Khattab AA
    Am J Cardiol; 2005 Sep; 96(5):681-4. PubMed ID: 16125495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update on tirofiban].
    Danchin N
    Presse Med; 2001 Jan; 30(2):93-4. PubMed ID: 11244822
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation.
    Sacristán D; López-Farré AJ; Zamorano-León JJ; Azcona L; Fernández-Ortiz A; Romero J; Farré J; Macaya C
    J Cardiovasc Pharmacol; 2008 Mar; 51(3):286-92. PubMed ID: 18356694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct subgroups of tirofiban-induced thrombocytopenia exist due to drug dependent antibodies that cause platelet activation and increased ischaemic events.
    Dunkley S; Evans S; Gaudry L; Jepson N
    Platelets; 2005 Dec; 16(8):462-8. PubMed ID: 16287613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged systemic delivery of tirofiban in a thrombus-laden saphenous vein graft.
    Gruberg L; Amikam S
    Int J Cardiovasc Intervent; 2003; 5(2):92-4. PubMed ID: 12745867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two i.v. antiplatelet agents marketed for coronary disease.
    Am J Health Syst Pharm; 1998 Jul; 55(14):1440, 1443. PubMed ID: 9676283
    [No Abstract]   [Full Text] [Related]  

  • 19. Transcranial Doppler ultrasonography-directed intravenous glycoprotein IIb/IIIa receptor antagonist therapy to control transient cerebral microemboli before and after carotid endarterectomy.
    van Dellen D; Tiivas CA; Jarvi K; Marshall C; Higman DJ; Imray CH
    Br J Surg; 2008 Jun; 95(6):709-13. PubMed ID: 18425794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
    Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
    Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.